Gerresheimer (GRRMF) Stock Price, News & Analysis

Company Overview

Gerresheimer AG (OTCMKTS: GRRMF) is a global provider of specialty glass and plastic packaging solutions, primarily serving the pharmaceutical, biotech, and life sciences industries, as well as the cosmetics and food sectors. Headquartered in Düsseldorf, Germany, the company leverages more than a century of expertise to design and manufacture high-precision packaging components that meet stringent regulatory and quality requirements. Gerresheimer’s offerings include glass vials, syringes, ampoules, cartridges, and inhalers, alongside a diverse range of cosmetic glass containers for perfumery and personal care applications.

With an integrated production network spanning Europe, the Americas, and Asia-Pacific, Gerresheimer operates state-of-the-art facilities in Germany, Poland, France, the United States, Mexico, Brazil, China, and India. These sites adhere to current Good Manufacturing Practices (cGMP) and ISO certifications, ensuring that products conform to global standards for safety, reliability, and performance. The company also provides filling machines, inspection equipment, and secondary packaging solutions, enabling clients to streamline their supply chains and accelerate market entry for new therapies and product lines.

Gerresheimer has a longstanding commitment to innovation in material science and sustainability. Investments in lightweight glass technology, plasma coating processes, and recycled plastics support both functional performance and environmental objectives. The firm collaborates closely with pharmaceutical developers and contract manufacturing organizations (CMOs) to co-develop customized packaging formats, including prefillable syringes and complex primary packaging systems designed for biologics, vaccines, and advanced drug delivery devices.

Founded in 1864 as a mechanical engineering workshop in Gerresheim, the company has evolved into a leading specialist in life-science packaging. Under the leadership of CEO Dr. Michael Hermle, Gerresheimer continues to expand its global footprint and technology portfolio, with a strategic focus on digitalization, operational excellence, and sustainability. By enhancing automation, quality control, and environmental performance, the company aims to support customers in meeting the growing demands of healthcare innovation and regulatory compliance worldwide.

Key Stats

• Today's Range: $56.75 to $56.75
• 50-Day Range: $50.46 to $73.80
• 52-Week Range: $50.46 to $114.50
• Volume: N/A
• Average Volume: 633 shs
• Market Capitalization: N/A
• P/E Ratio: 25.00
• Dividend Yield: 0.91%
• Price Target: N/A
• Consensus Rating: Hold

Gerresheimer Stock Analysis - MarketRank™

Gerresheimer scored higher than 5% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Gerresheimer.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Gerresheimer is 25.00, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 26.54.

Price to Earnings Ratio vs. Sector

The P/E ratio of Gerresheimer is 25.00, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.22.

Short Interest

• Score: 0.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 1696, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 16.08%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Gerresheimer pays a meaningful dividend of 1.30%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Gerresheimer does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Gerresheimer is 22.82%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Gerresheimer has a short interest ratio ("days to cover") of 1696, which indicates bearish sentiment.

Change versus previous month

Short interest in Gerresheimer has recently increased by 16.08%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Gerresheimer this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Gerresheimer insiders have not sold or bought any company stock.

Percentage Held by Institutions

53.23% of the stock of Gerresheimer is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

GRRMF Stock Analysis - Frequently Asked Questions

How have GRRMF shares performed this year?

Gerresheimer's stock was trading at $69.75 on January 1st, 2025. Since then, GRRMF shares have decreased by 18.6% and is now trading at $56.75.

How do I buy shares of Gerresheimer?

Shares of GRRMF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Instruments & Supplies
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:GRRMF
• CIK: N/A
• Web: www.gerresheimer.com
• Phone: 49 211 6181 00
• Fax: N/A
• Employees: 11,947
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 25.00
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A